does tirzepatide shrink your heart Associated with Lower Risk of and Kidney Damage Compared to Dulaglutide in Patients with Type 2 Diabetes and Cardiovascular Disease Tirzepatide is a unique medication

Moris D, Spartalis M, Spartalis E, Karachaliou GS, Karaolanis GI, Tsourouflis G, et al

Cardiovascular prevention with glucose-lowering drugs in type 2 diabetes: an evidence-based approach to the categories of primary and secondary prevention

Obesity-Related Health Issues Obesity often brings added challenges like insulin resistance, high cholesterol, or limited mobility

Leqembi was approved in 2023 in the United States

It will be recommended to repeat lab work in 3-4 months while on therapy to assess response

Thats because peptides degrade easily in the digestive tract and tend to be too large molecularly to permeate the skin or intestinal lining,5 often yielding a bioavailability as low as 1-2%.6 But there are some peptides that have a small enough molecular size that they easily transfer into the bloodstream as either an oral or a topical supplement